A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma
Clinical trial NCT06425302 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06425302
- Sponsor
- Celgene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-30
- Primary completion
- 2026-06-19
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.